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Summary 
One Health as a concept has been with us for many years, yet it is only recently that it is actively 
being discussed as a way of mitigating risks in society. The initiatives in the use of the concept 
require methods to monitor the benefits gain from a holistic approach to health, yet there is an 
absence of adequate frameworks to measure One Health benefits. The paper explores this 
problem with a review of the available literature and an examination of other potential 
methods. It concludes that most published work on One Health describes how this concept is 
valuable without trying to estimate the size or the type of value. A framework for measuring the 
benefits of a One Health approach is needed and through a process of an international 
workshop and the development of a One Health business case the authors are working towards 
its development.  
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Introduction 
The conjectured importance of zoonoses has prompted the scientific community and decision 
makers to look for holistic initiatives that incorporate the health and ecosystem sectors in order 
to improve understanding of the complex health relationships and to reduce national and global 
health risks. One Health recognises that the health of humans, animals and ecosystems are 
connected and advocates for coordinated, collaborative, interdisciplinary and cross-sectoral 
approaches. A harmonised and integrated approach – One Health – to mitigate health risks is 
appealing.  
However, global recognition of One Health approaches, for more effective protection of the 
global community from health threats, has not led to systematic resource allocation for 
integrated disease mitigation programmes. We argue that in part this is due to a lack of studies 
that assess the economic efficiency of One Health approaches and therefore a business case for 
such a change is poorly substantiated. While costs for One Health initiatives are easier to 
document, there is a lack of standardised and established methods for measuring the benefits of 
integrated programmes.  
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Definitions 
Several definitions of One Health have been presented since the term “One Medicine” was 
considered inadequate because it did not reflect the interactions between human and animal 
health that reach beyond individual clinical issues (1) and there is ongoing debate about what 
constitutes One Health. In the past it was mainly related to the interdependence of animal and 
human health, with the addition of environmental health. More recent definitions expand this to 
include other aspects that impact on health and well-being, in particular food security and 
poverty. For example, the Food and Agriculture Organisation of the United Nations (FAO) sees 
One Health as “a holistic vision to address complex challenges that threaten human and animal 
health, food security, poverty and the environments where diseases flourish” (2). Another 
definition of One Health requests that it demonstrates an added value to what human and 
animal health working in a disciplinary way can achieve: “added value in terms of human and 
animal health, financial savings or social and environmental benefits from closer cooperation of 
professionals in the health, animal and environment sectors at all levels of organisation” (3). 
The European Union (EU) uses a definition of One Health that refers to health hazards: “the 
improvement of health and wellbeing through: 
a) the prevention of risks and the mitigation of effects of crises that originate at the interface 
between humans, animals and their various environments,  
b) promoting a cross-sectoral, collaborative, ‘whole of society’ approach to health hazards, as a 
systemic change of perspective in the management of risks”. Similar to the previous definition it 
implies that One Health has a value, i.e. it refers to the improvement of health and wellbeing in 
comparison to a status quo (which is most likely a non-integrated, uni-sectoral or disciplinary 
approach). Other definitions do not refer to an added value, but rather describe the concept. For 
example, the American Veterinary Medical Association defines One Health as “the integrative 
effort of multiple disciplines working locally, nationally, and globally to attain optimal health for 
people, animals, and the environment” (4). As a working definition for the purpose of this paper, 
we suggest the following broad definition:  
One Health is a concept that addresses complex challenges to promote the health and 
well-being of all species through the integration of relevant sciences at systems level 
(based on (5)). 
The problem 
During the last five years there has been a growing momentum, particularly from the 
international community, requesting that health research, systems and services implement a 
One Health approach (6). Several projects and activities have been developed and are now 
working within this concept at the national, regional and global level (7) based on the 
expectation that a more holistic management of microbial health hazards would result in a more 
efficient use of the scarce resources available for mitigation of zoonotic disease risk. 
However, such a paradigm shift is not supported by systematic allocation of resources to 
integrated national or multinational programmes. At national level Ministries of Health and 
Agriculture (or Animal Health) remain largely separated with individual budgets and agendas 
(6). This is partly due to lack of convincing economic arguments in support of the approach, the 
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inertia of existing sectoral systems (6), information sharing and reporting barriers within and 
across institutions (8), lack of agreements of leadership, resource allocation and distribution of 
tasks among partners (9), (10), and insufficient indicators and measures of health (11) . There is 
also a lack of studies to estimate the costs of such a change.  
The examples where efficiency gains and the generation of net benefits to society have been 
demonstrated, are mainly single projects or small-scale modifications of health systems, 
because no country has taken a decision towards major funding of institutions whose main 
activity is One Health (6). To further the One Health cause and promote adoption globally, 
studies demonstrating the added value of One Health (in comparison to disciplinary, uni-
sectoral or non-integrated) approaches are needed (12). Another challenge identified is that 
One Health initiatives have a strong disease focus, but often fail to address ecosystem 
components, malnutrition (both under- and overnutrition), or poverty (12).  
Some economic evidence for One Health benefits exists, in particular referring to cost-savings 
and risk mitigation programmes for endemic zoonotic diseases, where strategic higher level 
budgetary and resource allocation provides sufficient financing to control disease along the 
livestock value chain leading to benefits in humans (6), (13–15). However, there is very sparse 
economic evidence about the economic efficiency of One Health surveillance systems, either 
analysed as independent strategies or incrementally; or the prevention of disease emergence 
(6). Economic analyses of One Health benefits resulting from strategies to reduce poverty or 
address malnutrition are hard to find. 
We argue that the underlying problem of limited and partial economic evidence on One Health 
lies in the absence of standardised methods to fully capture the complexity of benefits 
from taking a more holistic health approach. This is largely due to the disconnect between 
disciplines in the past, which has resulted in specific disciplinary metrics that fail to appreciate 
other disciplines. To date, health impact assessments, environmental impact assessments, 
agricultural impact evaluations and socio-economic impact analyses are performed. While some 
overlap exists across these approaches, there is no systematic methodology brought together to 
reflect the intertwined nature of health impacts across animal and human health sectors, 
environment and agriculture. For example, in agriculture and animal husbandry 
space, productivity is commonly used. Databases such as the Global Livestock Impact Mapping 
System (GLIMS), hosted by FAO, provides background data on biophysical, livestock population 
and production, socio-economic, animal health and trade parameters, but it does not explicitly 
link productivity losses to disease incidence nor human health impacts. Similar problems are 
seen in human health in which Disability Adjusted Life Years (DALYs) are used to rank disease 
impacts, but do not take into account impacts on livestock production, health and welfare, or the 
impact of a zoonotic disease in livestock or the threat of its emergence on people’s livelihoods 
and the wider societal aspects due to constraints in livestock sector development and food 
supply. DALYs also provide no information on the expenditure due to the presence or risk of 
disease or the lost opportunities in markets or the use of sub-optimal technologies in food 
systems (compare with animal disease impact assessments). This disciplinary isolation 
constrains the development of integrated data collection protocols and databases, and limits 
information on the priority of problems to be tackled and intervention points. 
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Consequently, there is a lack of combined metrics in complex systems that allow assessing the 
benefits of One Health initiatives in terms of their health (human and animal), economic, social, 
biological, environmental, and cultural benefits. The development of such metrics is not only a 
pre-requisite to assess whether One Health adds value compared to traditional approaches, but 
it also provides an important tool to assess the impact of multiple ongoing One Health initiatives 
at various levels.  
Aim 
One Health advocates for integrative health risk management at systems level to provide a 
comprehensive, strategic approach to future health challenges. Current impact assessment 
approaches do not cover the continuum of human through to animal health problems, and those 
which exist are often led by prioritisation processes dominated by expert opinion, which results 
in a stubborn institutionalization of programmes and preferential treatment of certain types of 
health problems. Questions need to be posed, therefore, about how we can estimate benefits 
from One Health in a standardised way to provide the economic evidence decision-makers need 
to allocate resources effectively (16).  
Commonly mentioned benefits of One Health to mitigate zoonotic disease risks include  
 increasing the benefit gained per resource unit used by sharing resources in the field 
 larger societal benefits through integrated valuation of the impact of disease mitigation 
on human and animal health 
 reduction of the likelihood of zoonotic disease emergence and establishment  
 reduction of uncertainty in disease mitigation decisions  
 improved information, data, knowledge and collaboration 
Our long term aim is to develop a framework that explicitly incorporates the heterogeneity of 
One Health and allows measurement of all dimensions of One Health benefits in a standardised 
and consistent way allowing for adequate comparisons or even meta-analyses in the future. As a 
first step towards this aim, a literature review has been conducted to identify metrics and 
associated methods presented so far in the scientific literature for assessing the benefits of One 
Health activities.  
Methodology 
A literature review was conducted in the scientific and grey literature to create an inventory of 
One Health benefits and the metrics used to measure those benefits. For the scientific literature 
search we used Scopus, PubMed and Web of Science, using a Title and Abstract search without 
any restrictions in terms of language, year, or similar. The search terms used were ([”One 
health” OR ecohealth] AND [effectiv* OR efficien* OR useful* OR benef* OR profit OR utility OR 
gain OR advantage OR value OR “losses avoid*” OR “cost avoid*” OR “costs avoid*” OR “cost 
sav*” OR “costs sav*”]). All references were extracted into Mendeley reference manager and 
screened independently by two researchers using primary exclusion criteria. When no abstract 
was available, the title was used to take a decision for inclusion or exclusion.  The exclusion 
criteria were: 
1) the reference did not refer to Ecohealth or One Health as a concept, and 
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2)  the reference did not refer to any kind of benefit or value. 
No secondary screening was considered necessary and all the articles were downloaded for a 
full text review and extracting of the information of interest. The same search terms were used 
in Google, where result pages were screened for relevant publications of any type (e.g. web 
presentations, reports, peer-reviewed publications) until three subsequent pages did not 
produce any further relevant results. These publications were added to the list of papers for full 
text review. Any other relevant publications found while reading the full text were added to the 
review. In addition to the publication details, the following information (where applicable) was 
extracted in the full text review: 
a. Output (e.g. intervention, programme, database, collaboration etc.) 
b. Benefits: type of benefit (free text), plus categorisation into economic, social, 
environmental, human health, animal health, or other benefit 
c. Type of article: conceptual, applied or other 
d. Metric used to measure benefit: yes/no 
e. If metric used: study objective, method/technique, target groups, data used, 
software, limitations, advantages 
Results 
In Scopus, 513 articles were found, in Pubmed 411 and in Web of Science 80 (a total of 621 
articles, of which 9 were duplicates). Of those 111 were kept for the full text screening. Thirty-
three additional publications were added from Google search, and 10 from the full text review.  
One Health benefits 
The different One Health benefits described in the publications reviewed are described in Table 
. Economic, social, technical, animal and human health, environmental and information benefits 
were listed. The majority of benefits described fell into the groups of more effective disease 
control and/or biosecurity measures (often related to infectious disease), improvement in both 
animal and human health and well-being as well as economic benefits.  
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Table I 
Benefits described in the publications found in the literature search 
Benefit described  Observation References 
Early detection of threat and timely, effective or rapid response, 
for example 
 Pets as sentinels (e.g. lead) poisoning 
 Use of mobile technology for integrated data collection 
 Prevent, detect, and combat future pandemics based on 
experience from H1N1 
 Improved understanding of health problem emergence and 
re-emergence in order to respond in a proportionate and 
timely manner 
Mostly intermediary 
benefit, with an 
expectation that early 
detection leads to rapid 
and effective response 
and therefore smaller 
outbreaks with smaller 
outbreak costs 
(17–26) 
Better/improved/more effective disease control and/or 
biosecurity measures (often related to infectious disease), e.g. 
 Improved understanding of the virulence mechanism and 
disease pathogenesis and disease epidemiology 
 Coordinated risk assessment 
 Tackle infectious disease problems in the system where is it 
most effective 
 Enhanced knowledge to efficaciously address public health 
aspects of emerging and re-emerging infectious diseases 
 More effective policies  
 Integrated study designs investigating health status in 
humans and animals simultaneously allow an instantaneous 
identification of the source of a zoonotic disease 
 Shared veterinary laboratory to diagnose brucellosis in febrile 
patients has brought the collaborating physician in to include 
brucellosis testing as a differential diagnosis to malaria and 
typhoid fever in an area where raw milk consumption is still 
prevalent. 
 (Improved) management or control of diseases in animals 
and/or humans 
 Effective understanding and prevention of disease evolution 
require a multidisciplinary or One Health approach 
The benefits described 
are largely referring to 
a technical 
intermediary outputs, 
without describing the 
final outcome, which 
would for example be 
less mortality or 
morbidity, higher 
productivity, etc.  
(1), (3), (9), 
(16), (17), 
(19), (25–39)  
Economic benefit / increase in economic efficiency, e.g.  
 Cost-effective reduction in disease transmission and 
incidence 
 Cost-savings by sharing resources (e.g. Reduction of logistic 
cost by 15%) 
 Human and animal health investigated as a single social 
system makes control more cost-effective (e.g. rabies, 
brucellosis – in comparison to looking at economic efficiency 
in one sector only) 
 Improved vaccination coverage at same or less costs 
 Efficient animal and human health systems 
 Economic growth 
Few studies report a 
demonstrated increase 
in economic efficiency 
due to One Health and 
these are referenced in 
the various 
publications many 
times.  
(1), (3), (5), 
(13–16), (25–
27), (36), 
(38), (40–50) 
Improvement in human or animal health or well-being, e.g.  
 Reduction of disease risk in humans and/or animals 
 Reduction in pandemic risk 
 Improved public health globally 
 Improved well-being because of human-animal bond 
 Increased physical activity resulting from dog ownership 
 Stronger motivation to quit smoking because endangers 
health of pet 
These are final benefits 
or outcomes that can be 
measured directly. 
(14), (26), 
(28), (29), 
(38), (42), 
(51–56) 
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Benefit described  Observation References 
 Improved food safety 
Higher quality or quantity of information, data; better 
knowledge, skills, e.g. 
 More information and insights (e.g. through knowledge 
exchange and transfer) 
 Improved knowledge 
 Comparative medicine – cross-fertilisation  
 New skills and experience 
 Capacity building 
 
These are mainly 
intermediary outputs 
that are of limited value 
if not used to do things 
in a better way (e.g. 
better knowledge or 
data are only of benefit 
if they are used in some 
way). Measurement of 
final outcome often 
lacking 
(1), (3), (13), 
(15), (26), 
(29), (36), 
(57–59) 
Ecosystem benefit, e.g. 
 Ecosystem resilience 
 Wildlife conservation 
 Environmentally friendly approaches 
 Inclusion of wider habitat, e.g. community based approach  
No studies that 
described a more 
concrete outcome, e.g. 
increase in animal 
populations  
(60–62) 
Personal or social benefits, e.g.  
 Increasing professional opportunities 
 Greater individual responsibility 
 Reduction in poverty and health related inequalities 
 Food security 
 Evidence-based decisions 
 Greater social cohesion 
 Empowerment of local communities 
 Trust 
Benefits that increase 
the well-being of 
people through various 
pathways, such as 
feelings of trust, pride 
or safety, bonds or 
nutrition 
(10), (27), 
(38), (62–65) 
Other 
 Foster new ideas and innovation through collaboration and 
exchange 
 (29), (66), 
(67) 
 
The benefits described range from rather specific measures focusing on one type of output (e.g. 
15% reduction in costs) to all-inclusive expected benefits referring to one or more hazards that 
could be disaggregated into their respective outcomes (e.g. Prevent, detect, and combat future 
pandemics of H1N1) and very broad aspects that are difficult to disaggregate (e.g. ecosystem 
resilience). Also, many of the benefits described are intermediaries (e.g. improved coordination, 
knowledge, skills, capacity, and management) that contribute to final benefits of improved 
health or economic efficiency. 
Metrics and associated methods used 
In the majority of studies, the expected or perceived benefits stemming from One Health were 
listed in a descriptive or conceptual way, and only a small number of studies reported a benefit 
measured either in non-monetary or monetary terms. These exceptions are listed in Table . 
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Table II 
Summary of measured One Health benefits 
Benefit  Metric Method Outcome Refer-
ences 
Cost-sharing initiative between 
medical and veterinary vaccination 
campaigns in rural Chad. Mobile 
veterinary vaccination teams 
already visited pastoral livestock 
keepers in this area to administer 
veterinary vaccines 
Monetary unit Cost evaluation 15 % reduction in operational 
costs compared with separate 
vaccination campaigns; cost per 
vaccinated child reduced from 
€30.3 to €11.9 
(46) 
Chad: a joint vaccination 
programme for humans and cattle 
had a higher human uptake 
particularly among women and 
children when animal vaccination 
was being offered concurrently 
Technical 
measure 
Measure 
vaccination 
rate 
A mean of 140 people were 
vaccinated a day during joint 
vaccination rounds compared 
with 100 people a day when 
veterinarians were absent 
(45) 
Reduction in vector density; 
greater individual responsibility of 
dengue control actions. 
Pupae per 
person index. 
Perception: 
who is 
responsible for 
dengue control  
Measurement 
of pupae per 
person; survey 
questionnaire 
The mean pupae per person 
index was significantly different 
in treatment and control areas, 
i.e. 0.19 vs. 0.73 ( p=0.024), and 
0.05 vs. 0.26 (p=0.019), more 
people in control area felt that 
dengue control was shared 
responsibility  
(30) 
Demonstrated benefit of 
vaccinating livestock for 
brucellosis on human and animal 
health 
Disability-
adjusted life 
years, cost of 
programme 
per DALY 
averted 
Cost-benefit 
and cost-
effectiveness 
analysis 
Cost-benefit analysis indicated 
that as an animal health 
intervention brucellosis 
vaccination of animals was not 
efficient. Looking at public health 
sector too, brucellosis control in 
livestock was a highly efficient 
intervention with a cost of less 
than $25 per disability-adjusted 
life year gained. 
(14) 
Echinococcosis mitigation in Spain 
achieved by education on disease 
risk in the human population, 
chemotherapy of all owned dogs in 
the area, euthanasia of stray dogs, 
sanitary disposal of offal from 
slaughterhouses and safe disposal 
of dead sheep by the construction 
of pits 
Monetary units 
for programme 
costs and 
benefits from 
the prevention 
of human cases  
and the 
improvement 
of sheep 
production  
Cost-benefit 
analysis 
By year 8 of the programme, the 
cumulative benefit-cost ratio had 
exceeded 1, indicating costs had 
been recouped 
(15) 
A new mitigation programme for 
Schistosomiasis in China 
integrating case detection and 
morbidity control in humans, 
molluscicide treatment, health 
education, surveillance, 
environmental management and 
livestock control initiatives 
resulted in effective disease control  
Monetary units 
for programme 
costs and 
benefits from 
the prevention 
of human cases 
averted 
Cost-benefit 
analysis 
The integrated programme 
created a net benefit for society of 
US $6.20 per US $1 invested 
(13) 
Rabies control in Chad through 
vaccination of dog population to 
avoid human cases and post-
Monetary units 
for programme 
costs and non-
Cost-
effectiveness 
analysis; 
Costs 50 USD per DALY averted; 
an effective dog mass-vaccination 
campaign, capable of interrupting 
(48) 
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Benefit  Metric Method Outcome Refer-
ences 
exposure treatment monetary units 
(number of 
exposures 
averted, 
number of 
cases averted) 
estimation of 
break-even 
point 
transmission, becomes cost- 
effective after 6 years, reaching 
32 USD per DALY. 
Early detection of  E. coli O157:H7 
outbreak leads to societal benefits 
Monetary units  Cost-benefit 
analysis 
Early detection of a single 
outbreak and averting at least 15 
human cases through the recall of 
25 million pounds of potentially 
contaminated beef, the 
surveillance and response system 
would recover all costs for the 5 
years of start-up and operation. 
(49) 
Investment in One Health systems 
for prevention and control of 
zoonotic diseases offers high 
expected benefits, with high rates 
of return  
Monetary units Cost-benefit 
analysis 
Estimates efficiency gains at 
global level between US$184 
million and US$506 million per 
year, or 10–16% if cooperation 
between the sectors through One 
Health is established 
(25) 
Use of an Escherichia coli O157:H7 
cattle vaccine to prevent human 
illness caused by consuming beef 
Monetary units Cost-benefit 
analysis 
Vaccinating the entire U.S. herd at 
a cost of between $2.29 and $9.14 
per unit (depending on overall 
effectiveness of the vaccine) 
would be a cost-effective 
intervention for preventing E. coli 
O157:H7 illness in humans 
(50) 
 
 
Discussion 
The problem identified for the presented study was not addressed through a systematic review 
of information on One Health and its benefits. The authors recognize that this may in part relate 
to structure of how the search was carried out. In particular,  by explicitly searching for the 
terms “One Health” or “Ecohealth”, some initiatives  that would fall under the  One Health 
definition, but were not labelled as such will have been missed, and in turn the measurement of 
the benefits of such activities. Nevertheless, previous (non-systematic) reviews reporting on the 
economics of One Health failed to identify additional studies. Consequently, there seems to be a 
real lack of studies reporting on the added value of One Health and its measurement.    
While there seems to be broad consensus in the published studies about the value of One 
Health, there is an evident lack of metrics and associated methods to estimate One Health 
benefits in a systematic way. There are slightly different needs in this regard. A large scale 
change in the level of government resource allocation needs clearly defined metrics on the cost 
of inputs to One Health and also measurable and comparable outcomes. This requires shifts in 
how governments carry out data collection and also the use of econometric methods to define 
the productivity gains from such a major shift in policy. 
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At grassroots level the needs are different and only a few studies use a scientific approach to 
measure and demonstrate the value of One Health. However, there are no studies that use 
randomized control trials or a case-control study design to actively investigate whether there is 
in fact an added value resulting from One Health. From a strictly scientific point of view, such 
studies would be needed to create the necessary evidence and basis for larger investments into 
One Health. This would require some element of comparison as used for example in case – 
control study designs or modelling approaches comparing the scenario of interest to a 
counterfactual. Because multiple One Health initiatives are already ongoing both at small and 
large scale, relevant data collection protocols should be established now to be able to make use 
of the data being generated during the change to a more comprehensive disease management 
approach.  
Due to its holistic nature One Health activities can result in a wide range of benefits spanning 
from social (e.g. empowerment, poverty reduction) to economic (e.g. cost reduction, economic 
growth), environmental (e.g. ecosystem resilience, wildlife conservation), and health aspects 
(e.g. improved well-being and public health). From the literature review, five large groups of 
benefits crystallise: 
1) protection of the environment and healthier ecosystems, 
2) enhanced social and cultural values, 
3) improvement in human and animal health and  well-being and animal welfare, 
4) better/improved/more effective/more rapid disease control and/or biosecurity measures  
 5) higher quality or quantity of information and data; better knowledge and skills. 
 Consequently, metrics from many different disciplines are needed to measure the resulting 
outputs and/or outcomes. Disciplinary approaches and methods for measurement are manifold; 
there is a wide range of methods used for economic impact assessment (e.g. cost-benefit 
analysis, economic surplus analysis, mathematical programming, general or partial equilibrium 
models), economic evaluation of health and health care health economics (e.g. cost of illness, 
cost-minimisation analysis, cost-effectiveness analysis, cost-utility analysis, cost-benefit 
analysis) or to value ecosystem services (e.g. market price method, productivity method, 
hedonic pricing, travel cost method, substitute cost method, benefit transfer method). Further, 
there are disciplines that offer a multitude of validated metrics and approaches, but that are 
usually not considered in One Health assessments, such as nutrition science. Yet, another 
complication arises through the fact that some benefits are realised quickly, while other benefits 
of a One Health approach may only manifest in the long term and thereby requiring the use of 
discounting of different values. This can be problematic when trying to compare natural and 
monetary units for example. 
Consequently, the key task does not seem to focus on the development of new metrics, but 
rather finding ways of integrating the established disciplinary metrics that are standardised and 
commonly used as well as combining qualitative and quantitative datasets. Only with a 
standardised approach accepted and applied by the scientific community can the necessary 
evidence base be created to assess the real value of One Health.  
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In summary, three key challenges follow from the above considerations that need to be 
addressed urgently by the scientific community: 
 The development of protocols to capture ongoing change 
 Integration of available disciplinary metrics 
 Data collection that captures One Health inputs and outcomes 
To address the scarcity of metrics and associated methods to estimate One Health benefits 
identified in the literature review and the shortcomings described above, the authors organized 
a workshop of international experts in public health, zoonotic diseases and economists who 
work on health issues. The findings of this workshop which was held in London in September 
2013, will be published shortly, focusing on how frameworks to capture benefits can be 
developed and applied. There is an urgent need for such work in the development of a One 
Health business case. 
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